Signaling Pathways - SUMOylation - CXCR - MDM2 - Insulin and Insulin-like Receptors
清除全部
- B1036 MLN49245 CitationTarget: NAE|Ubiquitin-activating Enzyme E1|SUMOylationSummary: NAE抑制剂
- B1465 Plerixafor 8HCl (AMD3100 8HCl)中文名: 普乐沙福八盐酸盐Target: CXCRSummary: CXCR4拮抗剂
- B1466 WZ811Target: CXCRSummary: 高效的CXCR4竞争性拮抗剂
- A8440 GSK1838705ATarget: Insulin and Insulin-like Receptors|ALKSummary: ATP竞争性IGF-IR/IR/ALK抑制剂
- A1302 GSK1904529ATarget: Insulin and Insulin-like ReceptorsSummary: IGF-1R/IR 选择性抑制剂
- A1185 BMS-754807Target: Insulin and Insulin-like ReceptorsSummary: 有效的、选择性的IGF-1R和InsR抑制剂
- A3803 SCH 563705Target: CXCRSummary: CXCR2/CXCR1拮抗剂
- A3802 SCH 5271235 CitationTarget: CXCRSummary: CXCR1和CXCR2拮抗剂
- A3762 RG71125 CitationTarget: MDM2Summary: MDM2抑制剂
- A3753 Reparixin L-lysine salt1 Citation中文名: 瑞帕利辛L-赖氨酸盐Target: CXCRSummary: CXCL8受体CXCR1/CXCR2活化的抑制剂